Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 820 | 2,417 | N/A | N/A | N/A |
| Receivables | 851 | 689 | N/A | N/A | N/A |
| Other current assets | 489 | 269 | 0 | 0 | 0 |
| TOTAL | $2,160 | $3,376 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 965 | 1,141 | N/A | N/A | N/A |
| Intangibles | 325 | 205 | 0 | 0 | 0 |
| Other Non-Current Assets | 5,502 | 2,311 | 0 | 0 | 0 |
| TOTAL | $6,792 | $3,656 | $N/A | $N/A | $N/A |
| Total Assets | $8,952 | $7,032 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,871 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,579 | 4,317 | 0 | 0 | 0 |
| TOTAL | $11,772 | $4,453 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,441 | 10,350 | N/A | N/A | N/A |
| Deferred Revenues | 468 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 12,549 | 11,113 | 0 | 0 | 0 |
| TOTAL | $21,162 | $21,644 | $N/A | $N/A | $N/A |
| Total Liabilities | $32,933 | $26,097 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Retained earnings | -48,935 | -42,269 | N/A | N/A | N/A |
| Other shareholders' equity | -17 | -17 | 0 | 0 | 0 |
| TOTAL | $-23,981 | $-19,065 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $8,952 | $7,031 | $0 | $0 | $0 |